Leave no-one behind: A retrospective study of hepatitis C testing and linkage to care for hospital inpatients.
Roder C, Cosgrave C, Mackie K, Roberts SK, Hellard ME, Wade AJ, Doyle JS
Hepatitis C
Interventions to eliminate hepatitis C: which ones suit your community?
Wade AJ, Doyle JS
Area-level social and economic factors and the local incidence of SARS-CoV-2 infections in Victoria during 2020.
Roder C, Maggs C, McNamara BJ, O'Brien D, Wade AJ, Bennett C, Pasco JA, Athan E
COVID-19
Efficacy and Safety of Sofosbuvir/Velpatasvir/Voxilaprevir for Hepatitis C Virus (HCV) NS5A-Inhibitor Experienced Patients With Difficult to Cure Characteristics.
Papaluca T, Roberts SK, Strasser SI, Stuart KA, Farrell G, MacQuillan G, Dore GJ, Wade AJ, George J, Hazeldine S, O'Beirne J, Wigg A, Fisher L, McGarity B, Sawhney R, Sinclair M, Thomas J, Valiozis I, Weltman M, Wilson M, Woodward A, Ahlenstiel G, Haque M, Levy M, Prewett E, Sievert W, Sood S, Tse E, Valaydon Z, Bowden S, Douglas M, New K, O'Keefe J, Hellard M, Doyle J, Stoove M, Thompson AJ
A survey of Australian general practitioners' hepatitis C knowledge and management 2 years after subsidised direct-acting antiviral therapy became available.
Gooey M, Wong E, Pedrana A, Allard N, Doyle J, Hellard M, Wade A
Psychiatric well-being among men leaving prison reporting a history of injecting drug use: A longitudinal analysis.
Stewart AC, Cossar R, Lee Wilkinson A, Scott N, Dietze P, Quinn B, Kinner SA, Aitken C, Walker S, Curtis M, Butler T, Ogloff JRP, Stoové M